RENAISSANCE TECHNOLOGIES LLC

Position in LITS — Lite Strategy, Inc.

CIK 1037389 NEW YORK, NY

Position in LITS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,147,562

-$876,290 QoQ

Shares Held

1,247,350

-28.5% QoQ

Ownership

4.10%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 35 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,825,954 across 312 Biotechnology names. LITS ranks #171 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,147,562	1,247,350	-28.5%	Shares	Sole	2026-08-13
2026-03-31	$2,023,852	1,744,700	+13.2%	Shares	Sole	2026-05-14
2025-12-31	$2,034,677	1,541,422	+51.3%	Shares	Sole	2026-02-12
2025-09-30	$2,465,208	1,018,681	+669.7%	Shares	Sole	2025-11-13
2025-06-30	$326,894	132,346	-1.6%	Shares	Sole	2025-08-13
2025-03-31	$294,436	134,446	-0.4%	Shares	Sole	2025-05-14
2024-12-31	$331,967	134,946	-2.0%	Shares	Sole	2025-02-13
2024-09-30	$392,291	137,646	-5.3%	Shares	Sole	2024-11-13
2024-06-30	$422,799	145,292	+1.5%	Shares	Sole	2024-08-09
2024-03-31	$572,368	143,092	-5.2%	Shares	Sole	2024-05-13
2023-12-31	$875,173	150,892	+4.6%	Shares	Sole	2024-02-13
2023-09-30	$1,011,164	144,246	-0.3%	Shares	Sole	2023-11-14
2023-06-30	$952,428	144,746	—	Shares	Sole	2023-08-11
No filing history on record for this holder in this stock.